Home | Privacy | Contact    

Information About Adult Leukemia


Leukemia - Symptoms, Types, Causes, Diagnoisis and Treatment ...
http://www.webmd.com/cancer/tc/leukemia-topic-overview Leukemia is cancer of the blood cells. It starts in the bone marrow, the soft tissue inside most bones. Bone marrow is where blood cells are made. more...
Acute Lymphocytic Leukemia: MedlinePlus - National Library of ...
http://www.nlm.nih.gov/medlineplus/acutelymphocyticleukemia.html What's New in Adult Acute Lymphocytic Leukemia Research? (American Cancer Society) Return to top; Journal Articles. References and abstracts from MEDLINE/PubMed (National ... more...
Adult Acute Lymphoblastic Leukemia Treatment (PDQ®) - National ...
http://www.cancer.gov/cancertopics/pdq/treatment/adultALL/Patient/page1 Expert-reviewed information summary about the treatment of adult acute lymphoblastic leukemia. more...
Adult Leukemia: A Comprehensive Guide for Patients and Families ...
http://shop.oreilly.com/product/9780596500016.do For the tens of thousands of Americans with adult leukemia, Adult Leukemia: A Comprehensive Guide for Patients and Families addresses diagnosis, medical tests ... more...
Acute Myeloid Leukemia (Adult) - Symptoms, Treatment and Prevention
http://www.healthscout.com/ency/1/640/main.html Symptoms, Treatment and Prevention of Acute Myeloid Leukemia (Adult) more...



Adult Leukemia News


adult leukemia - Bing News
IMPORTANT: Bing News RSS feed has moved!
Go to the new RSS page and renew your subscription.
read more...
Amgen's BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in
in 72 percent of read more...
Sorafenib targets acute myeloid
A drug used to treat kidney cancer also targets a genetic mutation active in about one third of patients with acute myeloid read more...
Wisconsin Chapter of The
These young adults and their families have survived lymphoma and read more...
Amgen Says BiTE Antibody Blinatumomab Achieved High Rate Of Complete Response
(RTTNews) - Amgen Inc. (AMGN: News ) announced updated results from a Phase 2 study that showed treatment with blinatumomab or AMG 103 helped achieve a high-rate of complete response or CR in 72 percent of read more...